Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- PMID: 14711538
- DOI: 10.1016/j.fertnstert.2003.10.004
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
Abstract
Since the 1990 National Institutes of Health-sponsored conference on polycystic ovary syndrome (PCOS), it has become appreciated that the syndrome encompasses a broader spectrum of signs and symptoms of ovarian dysfunction than those defined by the original diagnostic criteria. The 2003 Rotterdam consensus workshop concluded that PCOS is a syndrome of ovarian dysfunction along with the cardinal features hyperandrogenism and polycystic ovary (PCO) morphology. PCOS remains a syndrome, and as such no single diagnostic criterion (such as hyperandrogenism or PCO) is sufficient for clinical diagnosis. Its clinical manifestations may include menstrual irregularities, signs of androgen excess, and obesity. Insulin resistance and elevated serum LH levels are also common features in PCOS. PCOS is associated with an increased risk of type 2 diabetes and cardiovascular events.
Similar articles
-
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).Hum Reprod. 2004 Jan;19(1):41-7. doi: 10.1093/humrep/deh098. Hum Reprod. 2004. PMID: 14688154 Review.
-
Adolescents diagnosed with polycystic ovary syndrome under the Rotterdam criteria but not meeting the diagnosis under the updated guideline.Hum Reprod. 2024 May 2;39(5):1072-1077. doi: 10.1093/humrep/deae042. Hum Reprod. 2024. PMID: 38514450
-
Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.J Clin Endocrinol Metab. 2006 Mar;91(3):781-5. doi: 10.1210/jc.2005-2153. Epub 2006 Jan 17. J Clin Endocrinol Metab. 2006. PMID: 16418211
-
Best methods for identification and treatment of PCOS.Minerva Ginecol. 2010 Feb;62(1):33-48. Minerva Ginecol. 2010. PMID: 20186113 Review.
-
Polycystic ovary syndrome in adolescents.Best Pract Res Clin Endocrinol Metab. 2019 Jun;33(3):101272. doi: 10.1016/j.beem.2019.04.006. Epub 2019 Apr 13. Best Pract Res Clin Endocrinol Metab. 2019. PMID: 31027973 Review.
Cited by
-
Contribution of cervical incompetence to occurrence of second trimester abortion in patients with polycystic ovary syndrome during the frozen embryo transfer cycle.Front Endocrinol (Lausanne). 2024 Oct 16;15:1411618. doi: 10.3389/fendo.2024.1411618. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39479270 Free PMC article.
-
Relationship between polycystic ovary syndrome and high periostin level.Rev Assoc Med Bras (1992). 2024 Jul 19;70(6):e20240138. doi: 10.1590/1806-9282.20240138. eCollection 2024. Rev Assoc Med Bras (1992). 2024. PMID: 39045965 Free PMC article.
-
Obesity adversely affects serum anti-müllerian hormone (AMH) levels in Caucasian women.J Assist Reprod Genet. 2015 Sep;32(9):1305-11. doi: 10.1007/s10815-015-0538-7. Epub 2015 Jul 21. J Assist Reprod Genet. 2015. PMID: 26194744 Free PMC article.
-
Baseline AMH Level Associated With Ovulation Following Ovulation Induction in Women With Polycystic Ovary Syndrome.J Clin Endocrinol Metab. 2016 Sep;101(9):3288-96. doi: 10.1210/jc.2016-1340. Epub 2016 May 26. J Clin Endocrinol Metab. 2016. PMID: 27228369 Free PMC article. Clinical Trial.
-
Metformin during Pregnancy: Effects on Offspring Development and Metabolic Function.Front Pharmacol. 2020 Jun 17;11:653. doi: 10.3389/fphar.2020.00653. eCollection 2020. Front Pharmacol. 2020. PMID: 32625081 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical